Overview

Abdominal Wall Transplant

Status:
Recruiting

Trial end date:
2022-01-01

Target enrollment:

Participant gender:

Summary

The purpose of this protocol is to determine the safety and efficacy of abdominal wall transplantation as a treatment for the reconstruction of abdominal wall defects. Abdominal wall transplantation may be performed alone or in combination with another transplant.

Phase:

Phase 2

Details

Lead Sponsor:

Duke University
Linda Cendales

Collaborators:

Detlev Erdmann, M.D.
Kadiyala Ravindra, M.D.
Linda Cendales, MD

Treatments:

Abatacept
Immunosuppressive Agents